Relationship of HPVL1 and p16 expression with different cervical lesions

Scientific Research and Essays

Volumn 6, Issue 17, 2011, Pages 3724-3728

  Wu, Haiying ^a,b   Shi, Huirong ^a   Kong, Lingfei ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Cervical intraepithelial neoplasia; Cervical tumor; HPVL1 protein; Human papilloma virus; P16

Indexed keywords

HUMAN PAPILLOMAVIRUS;

EID: 80052415423     PISSN: None     EISSN: 19922248     Source Type: Journal    
DOI: 10.5897/sre11.845     Document Type: Article

References (27)

1. Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G (2001). Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod. Pathol., 14: 702-709.
2. Doorbar J (2005). The papillomavirus life cycle. J. Clin. Virol., 32: S7-S15.
3. Griesser H, Sander H, Hilfrich R, Moser B, Schenck U (2004). Correlation of immunochemical detection of HPV L1 capsid protein in Pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal. Quant. Cytol. Histol., 26: 241-245.
4. Kalof AN, Cooper K (2006). P16ink4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv. Anat. Pathol., 13: 190-194.
5. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M (2002). P16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol., 26: 1389-99.
6. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M (2001). Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer., 92: 276-84.
7. Koh J, Enders GH, Dynlacht BD, Harlow E (1995). Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375: 506-10.
8. Lambert AP, Anschau F, Schmitt VM (2006). P16ink4a expression in cervical premalignant and malignant lesions. Exp. Mol. Pathol., 80(2): 192-6.
9. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK (2003). Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J. Pathol., 200: 610-619.
10. Liu H, Shi J, Wilkerson M, Huang Y, Meschter S, Dupree W, Lin F (2007). Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections. Cancer, 111: 74-82.
11. Mäkitie AA, MacMillan C, Ho J, Shi W, Lee A, O'Sullivan B, Payne D, Pintilie M, Cummings B, Waldron J, Warde P, Irish J, Brown D, Gilbert R, Gullane P, Liu FF, Kamel-Reid S (2003). Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin. Cancer. Res., 9: 2177-2184.
12. Melsheimer P, Kaul S, Dobeck S, Bastert G (2003). Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA. Acta. Cytol., 47: 124-128.
13. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ (2003). P16ink4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J. Clin. Pathol., 56: 56-63.
14. Negri G, Bellisano G, Zannoni GF, Rivasi F, Kasal A, Vittadello F, Antoniazzi S, Faa G, Ambu R, Egarter-Vigl E (2008). P16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri. Am. J. Surg. Pathol., 32: 1715-20.
15. Ostor AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol., 12: 186-192.
16. Ozbun MA, Meyers C (1998). Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J. Virol., 72: 2715-2722.
17. Rauber D, Mehlhorn G, Fasching PA, Beckmann MW, Ackermann S (2008). Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. Eur. J. Obstet. Gynecol. Reprod. Biol., 140: 258-262.
18. Ruan YH, Wei WL, Zhang HX, Liang ZN, Liu BY, Chen Y (2003). Comparison and analysis of expression of c-myc and p16 in cervical carcinoma. Ai Zheng, 22(6): 602-606.
19. Serrano M, Hannon GJ, Beach D (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366: 704-707.
20. Stoler MH, Schiffman M (2001). Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA., 285: 1500-1505.
21. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V, Paraskevaidis E (2009). P16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev. 35: 210-220.
22. Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, Bliev A, Spitkovsky D, Ermilova V, Kisseljov F (2004). Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC. Cancer, 4: 58.
23. Xiao W, Bian M, Ma L, Liu J, Chen Y, Yang B, Wu Q (2010). Immunochemical analysis of human papillomavirus L1 capsid protein in liquid-based cytology samples from cervical lesions. Acta. Cytol., 54: 661-667.
24. Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T (2007). Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol. Res. Pract., 203: 445-449.
25. Yoshida T, Sano T, Kanuma T, Owada N, Sakurai S, Fukuda T, Nakajima T (2008). Imunochemical analysis of HPV L1 capsid protein and p16 rotein in liquid-based cytology samples from uterine cervical lesions. Cancer, 114: 83-88.
26. Yu L, Wang L, Zhong J, Chen S (2010). Diagnostic value of p16INK4A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens. Cancer. Cytopathol. 118: 47-55.
27. zur Hausen H (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol., 186: 131-56.